The Tri-Institutional MD-PhD Program (Tri-I) is a joint undertaking between Weill Cornell Medicine, The Rockefeller University, and Memorial Sloan Kettering Cancer Center. Trainees complete their MD degree at Weill Cornell Medical College, and PhD training at one of the three participating graduate schools: Weill Cornell Graduate School of Medical Sciences; the David Rockefeller Graduate Program in Bioscience; or the Louis V. Gerstner Jr. Graduate School of Biomedical Sciences. Tri-I guides students through a rigorous course of study that offers flexibility and unfettered access to experienced mentors in leading laboratories. An integrated curriculum reinforces the students’ identities as clinician-scientists; equally well-prepared to work in the laboratory and at the bedside, Tri-I graduates bridge the gap between clinical medicine and laboratory research. 

Learn more about the Tri-Institutional MD-PhD Program by watching the short video below.

Dianne Lumaquin, sixth year MD-PhD student, won first place in the Oral Presentation category for the 2022 Du Vigneaud Award for her presentation “Lipid Droplets are a Metabolic Vulnerability in Melanoma.” Ms. Lumaquin's talk was based on her research in the White Lab at MSK's Sloan Kettering Institute, where she is currently doing research toward her PhD.
Match Day, 2022, saw all 22 of the graduating Tri-I MD-PhD students match for a residency. The graduates will be going to some of the leading hospitals and residency programs in the country this summer to begin the next stage of their training.The 2022 MD-PhD matches were: